Skip to main content

Table 1 Cell surface markers of mesenchymal stem cells (MSCs) from four different sources

From: Current status and potential challenges of mesenchymal stem cell-based therapy for malignant gliomas

MSC source Cell surface marker References
Bone marrow Positive: SH2, SH3, CD29, CD44, CD71, CD73, CD124, CD90, CD105, CD106, CD120a
Negative: CD34, CD45, CD19, CD3, HLA-DR, CD31, CD11b
[12, 19, 24]
Adipose tissue Positive: CD13, CD29, CD44, CD73, HLA-I, CD90, CD105, CD166, HLA-ABC,
Negative: CD10, CD14, CD24, CD31, HLA-DR, CD36, CD38, CD45, CD49d, CD117, CD133, CD34, CD106, HLAII, SSEA4
[24, 44, 56, 72]
Umbilical cord Positive: CK8, CK18, CK19, CD10, CD13, HLA-I, CD29, CD73, CD105, CD106, CD90, CD44, CD73
Negative: CD14, CD31, CD33, CD34, HLA-DR, CD45, CD38, CD79, CD133, VWF
[9, 16, 24]
Human glioma Positive: CD90, CD105, CD73, CD44, CD151, α-SMA, desmin, VE-cadherin, NG2, STRO-1, HLA-I
Negative: CD31, CD34, CD133, CD45, HLA-DR, CD14, CD19, Nestin, SMM
[25, 85,86,87]